Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Al-Shamkhani

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Biotechnology|February 1, 1995
RNA enzymes as tools for gene ablationW James, A al-Shamkhani
European Journal of Immunology|November 10, 1998
Expression of the H52 epitope on the beta2 subunit is dependent on its interaction with the alpha subunits of the leukocyte integrins LFA-1, Mac-1 and p150,95 and the presence of Ca2+A Al-Shamkhani, S K Law
The British Journal of Surgery|July 19, 2019
Immuno-oncology for surgeonsS L Lee, A Al-Shamkhani, A Mirnezami
European Journal of Immunology|October 10, 2001
Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154L E Haswell, M J Glennie, A Al-Shamkhani
The Journal of Biological Chemistry|February 21, 1997
Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cellsA Al-Shamkhani, S Mallett, M H Brown, et al.
FEBS Letters|December 13, 2000
The effects of cysteine to alanine mutations of CD18 on the expression and adhesion of the CD11/CD18 integrinsS M Nolan, E C Mathew, S L Scarth, et al.
European Journal of Immunology|August 1, 1996
OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligandA al-Shamkhani, M L Birkeland, M Puklavec, et al.
Selective Cancer Therapeutics|January 1, 1991
Synthetic polymers conjugated to monoclonal antibodies: vehicles for tumour-targeted drug deliveryL W Seymour, P A Flanagan, A al-Shamkhani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID miceV Malmström, D Shipton, B Singh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Effect of integrin beta 2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression, and functionS M Tan, R H Hyland, A Al-Shamkhani, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Biotechnology|February 1, 1995
RNA enzymes as tools for gene ablationW James, A al-Shamkhani
European Journal of Immunology|November 10, 1998
Expression of the H52 epitope on the beta2 subunit is dependent on its interaction with the alpha subunits of the leukocyte integrins LFA-1, Mac-1 and p150,95 and the presence of Ca2+A Al-Shamkhani, S K Law
The British Journal of Surgery|July 19, 2019
Immuno-oncology for surgeonsS L Lee, A Al-Shamkhani, A Mirnezami
European Journal of Immunology|October 10, 2001
Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154L E Haswell, M J Glennie, A Al-Shamkhani
The Journal of Biological Chemistry|February 21, 1997
Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cellsA Al-Shamkhani, S Mallett, M H Brown, et al.
FEBS Letters|December 13, 2000
The effects of cysteine to alanine mutations of CD18 on the expression and adhesion of the CD11/CD18 integrinsS M Nolan, E C Mathew, S L Scarth, et al.
European Journal of Immunology|August 1, 1996
OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligandA al-Shamkhani, M L Birkeland, M Puklavec, et al.
Selective Cancer Therapeutics|January 1, 1991
Synthetic polymers conjugated to monoclonal antibodies: vehicles for tumour-targeted drug deliveryL W Seymour, P A Flanagan, A al-Shamkhani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID miceV Malmström, D Shipton, B Singh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Effect of integrin beta 2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression, and functionS M Tan, R H Hyland, A Al-Shamkhani, et al.
Pageof 2